Life Sciences: Biotechnology, Pharmaceuticals & Bioinformatics Life Sciences from A-Z
Innovation is at the core of life science companies and the protection of a life science company’s technology and innovations through patent acquisition is fundamental to the success of the company. As the life science company’s technology is developed over time, its new innovations must be protected by new patents. The resulting patent portfolio becomes the company’s most valuable asset for product and process protection, as collateral for investments, and as a vehicle for licensing, joint development, monetization, and partnerships. Our chemistry and life sciences patent attorneys are essential to our client’s efforts to commercialize and monetize their technology.
Areas of specialized expertise:
- Adjuvants
- Antibodies / Proteins
- Biologics
- Biomarkers
- Cell biology
- Cell culture
- Diagnostics
- Gene Editing
- Gene therapy
- Genomics
- Immunology
- Immunotherapy
- Liquid biopsy
- miRNA
- Molecular biology
- Nucleic acid sequencing and chemistry
- Personalized medicine
- Plant biology
- Proteomics
- RNA
- siRNA
- SNPs
- Stem cells
- Therapeutic proteins
- Vaccine
Biotechnology
Patents are valuable assets that biotechnology startups, emerging companies, and publicly traded companies can use to encourage investment, foster partnerships, and protect their IP. Patents are especially critical for biotechnology startups as they allow the company to protect its IP rights and provide a way to recoup research, development, and regulatory review investment costs.
Many of our life science and biotechnology patent practitioners have advanced degrees in a wide variety of disciplines spanning the entire spectrum of the biological arts. Our deep bench of patent practitioners has an unparalleled combination of experience, expertise, and skill sets. Their backgrounds include agricultural chemistry, biologics, cell biology, diagnostics, gene editing, gene therapy, genomics, immunology, immunotherapy, liquid biopsy, neuroscience, nucleic acid chemistry, plant biology, stem cells, and T-cell therapies.
Pharmaceuticals
Startups and pharmaceutical companies develop new compounds or small molecules as new drugs. Typically, the compound patents are drafted before any drug development or clinical trials. As the drug is further developed, formulations, and methods-of-treatment patent applications are drafted and prosecuted.
Our patent professionals have advanced degrees in chemistry or the life sciences and extensive experience with IP protection of pharmaceutical research and development. We help pharmaceutical companies protect their new drugs by preparing and prosecuting patent applications in the United States and throughout the world. We also help protect pharmaceutical formulations, polymorphs, and methods of treatment using the pharmaceuticals. In addition, we render opinions drawn to the validity of a patent or the freedom-to-operate of a new pharmaceutical or formulation. Our practitioners also perform prior art searching which can be used in a landscape analysis or in competitive intelligence.
Bioinformatics
The application of innovative data-driven approaches such as bioinformatics and artificial intelligence to the life science sector has brought about a change in the way that biological inventions can be protected by patent laws. Kilpatrick attorneys use patent filing and prosecution strategies often developed in the fields of computer science and business methods to aid our clients in protecting certain aspects of their data-driven innovations, which include computer-implemented tools, methods of doing business, and uses of insights discovered from data as well as more traditional biotechnological products and processes.
Many of our highly skilled patent attorneys and staff have graduate degrees in bioinformatics/computational biology, computer science, medical technology, electrical engineering, mathematics, and physics coupled with extensive experience working for various biotechnology, health, and software technology companies, universities, and government organizations.
Insights View All
Primary Contacts View All
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.